Skip to main content
. 2020 Jun 1;39(2):176–185. doi: 10.1007/s12664-020-01047-6

Table 2.

Participant characteristics based on inclusion criteria. IBD inflammatory bowel disease, TNF tumor necrosis factor

Number of patients with IBD treated per month, (168 responses)
    5–10 81 (34.3%)
   11-20 39 (16.5%)
   20-30 27 (11.4%)
      > 30 21 (8.9%)
No. of patients with IBD treated with anti-TNF per month, (104 responses)
    1–4 94 (56.3%)
     5-10 10 (6%)
   11-20   0 (0%)